Pterygium: degeneration, exuberant wound healing or benign neoplasm?

Article Sidebar

PDF
Published: Feb 29, 2016
DOI: https://doi.org/10.18051/UnivMed.2009.v28.179-187 Universa Medicina
Abstract Viewed: 336
PDF Downloaded: 200
Keywords:
Pterygium apoptosis growth neoplasm

Main Article Content

Nurbuanto Tradjutrisno
Department of Ophthalmology, Gatot Subroto Central Military Hospital

Abstract

Pterygium is a condition characterized by the encroachment of a fleshy triangle of conjunctival tissue into the cornea. Despite various studies, the pathogenesis of pterygium remains unclear. Chronic exposure to sun is the only factor of which the role has been clearly documented by epidemiologic and in vitro studies. Recent studies have provided data such as loss of heterozygosity and microsatellite instability, decreased apoptosis, increased growth factors, increased p53 expression, telomerase activity, and presence of oncogenic viruses, which support the concept that pterygia can be considered a neoplastic condition. Some of results are contradictory and some features were only found in a proportion of pterygia; this may be due to differences in methodology and study population, but may also be indicative of multiple causative factors. This implies that the pterygium should be viewed as a final common outcome of various etiological factors, such as geography and ethnicity, with ultraviolet radiation-induced damage as the main factor. Thus the pterygium remains an enigma, having the features of an exuberant growth but also those of a benign neoplasm. In this connection there is a need for a unifying theory capable of explaining all of the characteristics of the pterygium.

Article Details

How to Cite
Tradjutrisno, N. (2016). Pterygium: degeneration, exuberant wound healing or benign neoplasm?. Universa Medicina, 28(3), 179–187. https://doi.org/10.18051/UnivMed.2009.v28.179-187
Issue
Vol. 28 No. 3 (2009)
Section
Review Article

The journal allows the authors to hold the copyright without restrictions and allow the authors to retain publishing rights without restrictions.

References

Coroneo MT, Di Girolamo N, Wakefield D. The pathogenesis of pterygia. Curr Opin Ophthalmol 1999;10:282–8.

Gazzard G, Saw SM, Farook M, Koh D, Widjaja D, Chia SE, et al. Pterygium in Indonesia: prevalence, severity and risk factors. Br J Ophthalmol 2002;86:1341–6.

Wong TY, Foster PJ, Johnson GJ, Seah SK, Tan DT. The prevalence and risk factors for pterygium in an adult Chinese population in Singapore: the Tanjong Pagar survey. Am J Ophthalmol 2001;131: 76–83.

Kanski JJ. Clinical ophthalmology: a systematic approach. 5th ed. Butterworth-Heinemann: Edinburgh;2003.

Fuchs E. Uber das pterygium. Albert von Graefes Arch Klin Exp Ophthalmol 1892;38:1. Cited by Gheck L, Dupas B, Denion E, Amar N, Baudouin C. Apport de la microscopie confocale in vivo à l’étude des ptérygions. [Advantages of the in vivo confocal microscope for investigation of the pterygium]. J Fr Ophtalmol 2007;30:3-10.

Gheck L, Dupas B, Denion E, Amar N, Baudouin C. Apport de la microscopie confocale in vivo à l’étude des ptérygions. [Advantages of the in vivo confocal microscope for investigation of the pterygium]. J Fr Ophtalmol 2007;30:3-10.

Vogt J, Harrison BJ, Spearman H, Cossins J, Vermeer S, Cate LN, et al. Mutation analysis of CHRNA1, CHRNB1, CHRND, and RAPSN genes in multiple pterygium syndrome/fetal akinesia atients. Am J Hum Genet 2008;82:222–7.

Buratto L, Phillips RL, Carito G. Clinical anatomy. In: Pterygium surgery. Buratto L, Phillips RL, Carito GC, editors. Thorofare:Slack;2000.p.17-20.

Detorakis ET, Spandidos DA. Pathogenetic mechanisms and treatment options for ophthalmic pterygium: trends and perspectives. Intl J Mol Med 2009;23:439-47.

Di Girolamo N, Tedla N, Kumar RK, McCluskey P, Lloyd A, Coroneo M, et al. Culture and chracterisation of epithelial cells from human pterygia. Br J Ophthalmol 1999;83:1077-82.

Pellegrini G, Traverso CE, Franzi AT, Zingirian M, Cancedda R, De Luca M. Long-term restoration of damaged corneal surfaces with autologous cultivated corneal epithelium. Lancet 1997;349: 990-3.

Dushku N, John M, Schultz GS, Reid TW. Pterygia pathogenesis: corneal invasion by matrix metalloproteinase expressing altered limbal epithelial basal cells. Arch Ophthalmol 2001;119: 695-6.

Tong L, Chew J, Yang H, Ang LPK, Tan DTH, Beuerman RW. Distinct gene subsets in pterygia formation and recurrence: dissecting complex biological phenomenon using genome wide expression data. BMC Med Genomics 2009;2:14.

Dushku N, Reid TW. p53 expression in altered limbal basal cells of pingueculae, pterygia, and limbal tumors. Curr Eye Res 1997;16:1179-92.

Weinstein O, Rosenthal G, Zirkin H, Monos T, Lifshitz T, Argov S. Overexpression of p53 tumor suppressor gene in pterygia. Eye 2002;16:619–21.

Schellini SA, Hoyama E, Oliveira DE, Bacchi CE, Padovani CR. Expressão da metaloprotease de matriz-9 no pterígio [Matrix metalloproteinase-9 expression in pterygium]. Arq Bras Oftalmol 2006; 69:61-4.

Schneider BG, John-Aryankalayil M, Rowsey JJ, Dushku N, Reid TW. Accumulation of p53 protein in pterygia is not accompanied by TP53 gene mutations. Exp Eye Res 2006;82:91-8.

Tsai YY, Cheng YW, Lee H, Tsai FJ, Tseng SH, Chang KC. P53 gene mutation spectrum and the relationship between gene mutation and protein levels in pterygium. Mol Vis 2005;11:50-5.

Perra MT, Maxia C, Corbu A, Minerba L, Demurtas P, Colombari R, et al. Oxidative stress in pterygium: relationship between p53 and 8-hydroxy-deoxyguanosine. Mol Vis 2006;12:136-42.

Rodrigues FW, Arruda JT, Silva RE, Moura KKVO. TP53 gene expression, codon 72 polymorphism and human papillomavirus DNA associated with pterygium. Gen Mol Res 2008;7:1251-8.

Ke M, Sun Z, Wang L. Expression of MMP-1, MMP-9 and TGF-ß1 in human pterygium and its clinical significance. FASEB J 2007;21:711-18.

John-Aryankalayil M, Dushku N, Jaworski CJ, Cox CA, Schultz G, Smith JA, et al. Microarray and protein analysis of human pterygium. Mol Vis 2006; 12:55-64.

Chui J, Di Girolamo N, Coroneo MT, Wakefield D. The role of substance P in the pathogenesis of pterygia. Invest Ophthalmol Vis Sci 2007;48:4482–9.

Chiang CC, Cheng YW, Lin CL, Lee H, Tsai FJ, Tseng SH, et al. Cyclooxygenase 2 expression in pterygium. Mol Vis 2007;13:635-8.

Tsai YY, Cheng YW, Lee H, Tsai FJ, Tseng SH, Chang KC. P53 gene mutation spectrum and the relationship between gene mutation and protein levels in pterygium. Mol Vis 2005;11:50-5.

Park TK, Jin KH. Telomerase activity in pterygial and normal conjunctival epithel-ium. Korean J Ophthalmol 2000;14:85-9.

Aspiotis M, Tsanou E, Gorezis S, Ioachim E, Skyrlas A, Stefaniotou M, et al. Angiogenesis in pterygium: study of microvessel density, vascular endothelial growth factor, and thrombospondin-1. Eye 2007;21:1095–101.

Tekelioglu Y, Turk A, Avunduk AM, Yulug E. Flow cytometrical analysis of adhesion molecules, T-lymphocyte subpopulations and inflammatory markers in pterygium. Ophthalmologica 2006;220: 372–8.

Piras F, Moore PS, Ugalde J, Perra MT, Scarpa A, Sirigu P. Detection of human papillomavirus DNA in pterygia from different geographical regions. Br J Ophthalmol 2003;87:864-6.

Gallagher MJ, Giannoudis A, Herrington CS, Hiscott P. Human papillomavirus in pterygium. Br J Ophthalmol 2001;85:782–4.

Ueda Y, Kanazawa S, Kitaoka T, Dake Y, Ohira A, Ouertani AM, et al. Immunohistochemical study of p53, p21 and PCNA in pterygium. Acta Histochem 2001;103:159-65.